What is the Glaxosmithkline Pharmaceuticals Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 4.75% of the total equity shares of Glaxosmithkline Pharmaceuticals Ltd.

What is the Glaxosmithkline Pharmaceuticals Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 8.48% of the total equity shares of Glaxosmithkline Pharmaceuticals Ltd.

How has the Glaxosmithkline Pharmaceuticals Ltd promoter holding changed?

The promoter holding in Glaxosmithkline Pharmaceuticals Ltd changed from 75.00% to 75.00% during the latest reported period.

How has the Glaxosmithkline Pharmaceuticals Ltd FII holding changed?

The FII holding in Glaxosmithkline Pharmaceuticals Ltd changed from 4.79% to 4.75% during the latest reported period.

How has the Glaxosmithkline Pharmaceuticals Ltd DII holding changed?

The DII holding in Glaxosmithkline Pharmaceuticals Ltd changed from 7.80% to 8.48% during the latest reported period.

Who are the major shareholders of Glaxosmithkline Pharmaceuticals Ltd?

The major shareholders of Glaxosmithkline Pharmaceuticals Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Glaxosmithkline Pharmaceuticals Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Glaxosmithkline Pharmaceuticals Ltd public shareholding?

Public shareholders hold 11.77% of the total equity shares of Glaxosmithkline Pharmaceuticals Ltd as per the latest available data.

Glaxosmithkline Pharmaceuticals Ltd Share Price

Detail Overview

Pharmaceuticals - MultinationalNSE

₹2,404.70

-29.00(-1.19%)

As on 23 Oct 2026 at 15:57

As of 23 Oct 2026 at 15:57, Glaxosmithkline Pharmaceuticals Ltd is trading at ₹2,404.70. The 52-week range stands at ₹2,088.10–₹3,120.70, with a market cap of ₹40.74 thousand crore. At a P/E of 38.49 and a dividend yield of 2.37%, it is a large-cap stock in the Pharmaceuticals sector.